Wuxi AppTec Co (HKSE:02359) Valuation Rank

View and export this data going back to 2018. Start your Free Trial

What is Wuxi AppTec Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Wuxi AppTec Co Valuation Rank Related Terms

Thank you for viewing the detailed overview of Wuxi AppTec Co's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Wuxi AppTec Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Wuxi AppTec Co Ltd (HKSE:02359) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

WUXIF:USA WUXAY:USA WX8:Germany 603259:China

Address

288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, CHN, 200131

Website

https://www.wuxiapptec.com

Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by China, Europe, and other regions.

Executives

Jpmorgan Chase & Co.
Fmr Llc	2201 Interest of corporation controlled by you
Ubs Group Ag	2201 Interest of corporation controlled by you
Morgan Stanley	2201 Interest of corporation controlled by you
Blackrock, Inc.	2201 Interest of corporation controlled by you
Citigroup Inc.	2201 Interest of corporation controlled by you
Schroders Plc	2102 Investment manager
Computershare Hong Kong Trustees Limited	2301 Trustee
The Capital Group Companies, Inc.	2201 Interest of corporation controlled by you
The Goldman Sachs Group, Inc.
Brown Brothers Harriman & Co.	2502 Approved lending agent
Pandanus Partners L.p.	2201 Interest of corporation controlled by you
Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Fil Limited	2201 Interest of corporation controlled by you
Bank Of America Corporation